Zobrazeno 1 - 10
of 203
pro vyhledávání: '"A P, Menday"'
Autor:
Streit, A., Erwin, D., Lippert, Th., Mallmann, D., Menday, R., Rambadt, M., Riedel, M., Romberg, M., Schuller, B., Wieder, Ph.
The UNICORE Grid-technology provides a seamless, secure and intuitive access to distributed Grid resources. In this paper we present the recent evolution from project results to production Grids. At the beginning UNICORE was developed as a prototype
Externí odkaz:
http://arxiv.org/abs/cs/0502090
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
D.A. Haxby
Publikováno v:
Probation. 9:59-60
Autor:
Haxby, D.A.
Publikováno v:
Probation Journal; December 1959, Vol. 9 Issue: 4 p59-60, 2p
Publikováno v:
Journal of Antimicrobial Chemotherapy. 52:1005-1010
Objectives To investigate the correlation between non-hospital antimicrobial consumption and resistance. Methods Information on the non-hospital sales of antimicrobials from 14 European countries in 1997 and 2000 was compared with the antimicrobial r
Publikováno v:
Journal of Dermatological Treatment. 10:25-29
Personal expenditure arising from psoriasis by patients with mild/moderate chronic plaque psoriasis was assessed before and at the end of randomized treatment in 122 patients treated with calcipotriol for a mean of 12 weeks and in 110 patients treate
Publikováno v:
British Journal of Dermatology. 139:1005-1011
In a multicentre, randomized, open study, 306 patients of either sex, over 18 years of age with stable chronic plaque psoriasis > 100 cm2 in surface area, and who gave informed consent, applied Dovonex (calcipotriol) ointment (50 micrograms/g) twice
Publikováno v:
British Journal of Cancer
Preclinical studies have shown that the vitamin D analogue EB 1089 has significantly less calcaemic activity than its parent compound 1,25-dihydroxyvitamin D (1,25(OH)2D3) and significant anti-tumour activity. This phase I trial was designed to evalu
Publikováno v:
Journal of Dermatological Treatment. 9:15-19
The efficacy, tolerability and acceptability of betamethasone valerate 0.1%/fusidic acid 2% cream and betamethasone valerate 0.1%/clioquinol 3% cream were compared in 120 patients of either sex, aged 18 years or over, with a clinical diagnosis of inf